Proteonomix Company Insiders
| PROT Stock | USD 0.0001 0.00 0.00% |
Proteonomix employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 42 years, averaging almost 8.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Proteonomix's management performance can provide insight into the firm performance.
| Michael Cohen Chairman Founder, Chairman, CEO and President and COO |
Proteonomix | Build AI portfolio with Proteonomix Stock |
Proteonomix Management Team Effectiveness
The company has return on total asset (ROA) of (0.5099) % which means that it has lost $0.5099 on every $100 spent on assets. This is way below average. Proteonomix's management efficiency ratios could be used to measure how well Proteonomix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.33 in 2025, whereas Return On Tangible Assets are likely to drop (6.60) in 2025. Change To Liabilities is likely to gain to about 516.7 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 5.4 M in 2025.Net Loss is likely to drop to about (1.7 M) in 2025
Proteonomix Workforce Comparison
Proteonomix is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 54.0. Proteonomix adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Proteonomix Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Proteonomix Price Series Summation is a cross summation of Proteonomix price series and its benchmark/peer.
Proteonomix Notable Stakeholders
A Proteonomix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Proteonomix often face trade-offs trying to please all of them. Proteonomix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Proteonomix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Cohen | Founder, Chairman, CEO and President and COO | Profile | |
| Steven Byle | Chief Technical Officer, Director | Profile | |
| Steven JD | CTO Director | Profile | |
| Jason Isaacs | Secretary | Profile | |
| Jaci Mandil | Chief Proteoderm | Profile |
About Proteonomix Management Performance
The success or failure of an entity such as Proteonomix often depends on how effective the management is. Proteonomix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Proteonomix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Proteonomix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (6.29) | (6.60) | |
| Return On Capital Employed | 0.32 | 0.33 | |
| Return On Assets | (0.48) | (0.50) | |
| Return On Equity | 0.43 | 0.41 |
Please note, the imprecision that can be found in Proteonomix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Proteonomix. Check Proteonomix's Beneish M Score to see the likelihood of Proteonomix's management manipulating its earnings.
Proteonomix Workforce Analysis
Traditionally, organizations such as Proteonomix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Proteonomix within its industry.Proteonomix Manpower Efficiency
Return on Proteonomix Manpower
| Revenue Per Employee | 5.2K | |
| Revenue Per Executive | 5.2K | |
| Net Loss Per Employee | 276.8K | |
| Net Loss Per Executive | 276.8K |
Additional Tools for Proteonomix Stock Analysis
When running Proteonomix's price analysis, check to measure Proteonomix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proteonomix is operating at the current time. Most of Proteonomix's value examination focuses on studying past and present price action to predict the probability of Proteonomix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proteonomix's price. Additionally, you may evaluate how the addition of Proteonomix to your portfolios can decrease your overall portfolio volatility.